Speaker illustration

Doctor Aurelie Boucard

OP2 Drugs, Bordeaux (France)

A specific complex I-induced ROS modulator, OP2113, is a new cardioproctective agent against acute myocardial infarction injuries during reperfusion.

Event: ESC CONGRESS 2019

Topic: Pharmacotherapy

Session: Acute coronary syndrome treatment

Thumbnail

ESC 365 is supported by

logo Novo Nordisk